Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rolf D Issels

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2002
Tumor-derived heat shock protein 70 peptide complexes are cross-presented by human dendritic cellsElfriede Noessner, Robert Gastpar, Valeria Milani, et al.
Cancers|February 25, 2022
VISTA in Soft Tissue Sarcomas: A Perspective for Immunotherapy?Markus Albertsmeier, Annelore Altendorf-Hofmann, Lars H Lindner, et al.
Cancers|December 8, 2020
Cancer Testis Antigens and Immunotherapy: Expression of PRAME Is Associated with Prognosis in Soft Tissue SarcomaMarkus Albertsmeier, Annelore Altendorf-Hofmann, Lars H Lindner, et al.
Annals of Surgery|November 8, 2014
Effectiveness of regional hyperthermia with chemotherapy for high-risk retroperitoneal and abdominal soft-tissue sarcoma after complete surgical resection: a subgroup analysis of a randomized phase-III multicenter studyMartin K Angele, Markus Albertsmeier, Niclas J Prix, et al.
Cancers|April 3, 2021
Neoadjuvant Chemoradiation Combined with Regional Hyperthermia in Locally Advanced or Recurrent Rectal CancerOliver J Ott, Cihan Gani, Lars H Lindner, et al.
International Journal of Cancer|March 3, 2016
Hyperthermia adds to trabectedin effectiveness and thermal enhancement is associated with BRCA2 degradation and impairment of DNA homologous recombination repairDominique Harnicek, Eric Kampmann, Kirsten Lauber, et al.
European Journal of Cancer (Oxford, England : 1990)|October 19, 2021
Immune infiltrates in patients with localised high-risk soft tissue sarcoma treated with neoadjuvant chemotherapy without or with regional hyperthermia: A translational research program of the EORTC 62961-ESHO 95 randomised clinical trialRolf D Issels, Elfriede Noessner, Lars H Lindner, et al.
Cancer Immunology, Immunotherapy : CII|April 17, 2025
Durable response to nivolumab in combination with regional hyperthermia in a patient with PD-L1-negative metastatic head and neck squamous cell carcinomaLuc M Berclaz, Anton Burkhard-Meier, Axel Lechner, et al.
JAMA Oncology|February 17, 2018
Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma: The EORTC 62961-ESHO 95 Randomized Clinical TrialRolf D Issels, Lars H Lindner, Jaap Verweij, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|January 11, 2020
Systemic antitumor effect by regional hyperthermia combined with low-dose chemotherapy and immunologic correlates in an adolescent patient with rhabdomyosarcoma - a case reportRolf D Issels, Lars H Lindner, Michael von Bergwelt-Baildon, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2002
Tumor-derived heat shock protein 70 peptide complexes are cross-presented by human dendritic cellsElfriede Noessner, Robert Gastpar, Valeria Milani, et al.
Cancers|February 25, 2022
VISTA in Soft Tissue Sarcomas: A Perspective for Immunotherapy?Markus Albertsmeier, Annelore Altendorf-Hofmann, Lars H Lindner, et al.
Cancers|December 8, 2020
Cancer Testis Antigens and Immunotherapy: Expression of PRAME Is Associated with Prognosis in Soft Tissue SarcomaMarkus Albertsmeier, Annelore Altendorf-Hofmann, Lars H Lindner, et al.
Annals of Surgery|November 8, 2014
Effectiveness of regional hyperthermia with chemotherapy for high-risk retroperitoneal and abdominal soft-tissue sarcoma after complete surgical resection: a subgroup analysis of a randomized phase-III multicenter studyMartin K Angele, Markus Albertsmeier, Niclas J Prix, et al.
Cancers|April 3, 2021
Neoadjuvant Chemoradiation Combined with Regional Hyperthermia in Locally Advanced or Recurrent Rectal CancerOliver J Ott, Cihan Gani, Lars H Lindner, et al.
International Journal of Cancer|March 3, 2016
Hyperthermia adds to trabectedin effectiveness and thermal enhancement is associated with BRCA2 degradation and impairment of DNA homologous recombination repairDominique Harnicek, Eric Kampmann, Kirsten Lauber, et al.
European Journal of Cancer (Oxford, England : 1990)|October 19, 2021
Immune infiltrates in patients with localised high-risk soft tissue sarcoma treated with neoadjuvant chemotherapy without or with regional hyperthermia: A translational research program of the EORTC 62961-ESHO 95 randomised clinical trialRolf D Issels, Elfriede Noessner, Lars H Lindner, et al.
Cancer Immunology, Immunotherapy : CII|April 17, 2025
Durable response to nivolumab in combination with regional hyperthermia in a patient with PD-L1-negative metastatic head and neck squamous cell carcinomaLuc M Berclaz, Anton Burkhard-Meier, Axel Lechner, et al.
JAMA Oncology|February 17, 2018
Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma: The EORTC 62961-ESHO 95 Randomized Clinical TrialRolf D Issels, Lars H Lindner, Jaap Verweij, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|January 11, 2020
Systemic antitumor effect by regional hyperthermia combined with low-dose chemotherapy and immunologic correlates in an adolescent patient with rhabdomyosarcoma - a case reportRolf D Issels, Lars H Lindner, Michael von Bergwelt-Baildon, et al.
Pageof 5